Data is not available at this time.
Korian is a leading European provider of elderly care and specialized health services, operating across France, Germany, Italy, Spain, the Netherlands, and Belgium. The company’s revenue model is anchored in long-term care nursing homes, assisted living facilities, and home care services, catering to aging populations with increasing demand for medical and non-medical support. With approximately 850 care facilities and 91,808 beds as of 2021, Korian holds a strong market position in Europe’s fragmented elderly care sector. The company differentiates itself through integrated care solutions, combining residential, clinical, and home-based services to address diverse patient needs. Its geographic diversification mitigates country-specific regulatory risks while capitalizing on Europe’s aging demographic trends. Korian faces competition from public providers and smaller private operators but benefits from scale advantages in staffing, procurement, and regulatory compliance. The company’s focus on specialized care for chronic conditions and post-acute recovery further strengthens its positioning in higher-margin segments of the healthcare continuum.
Korian reported FY2023 revenue of €4.996 billion, reflecting its large-scale operations in elderly care. However, the company posted a net loss of €92.4 million, with diluted EPS of -€0.87, indicating profitability challenges amid rising operational costs and potential regulatory pressures. Operating cash flow remained robust at €804.2 million, supporting liquidity despite significant capital expenditures of €484.1 million for facility maintenance and expansion.
The company’s negative net income suggests strained earnings power, likely due to high fixed costs in labor-intensive care facilities and debt servicing. Capital efficiency is pressured by substantial investments in maintaining and modernizing its extensive facility network, though operating cash flow generation demonstrates underlying cash-generating ability from core operations.
Korian’s balance sheet shows €677.9 million in cash against a high total debt burden of €8.14 billion, reflecting leveraged expansion in a capital-intensive sector. The debt-heavy structure may constrain financial flexibility, particularly in a rising interest rate environment, though the asset-backed nature of its real estate portfolio provides some collateral support.
Growth is driven by Europe’s aging population, but recent financial performance shows strain. The company suspended dividends (€0 DPS in FY2023) to preserve capital, prioritizing debt management and operational stability over shareholder returns. Long-term demand trends remain favorable, but short-term execution risks persist.
With a market cap of €1.17 billion and a beta of 0.839, Korian trades at a discount to revenue multiples, reflecting investor concerns over profitability and leverage. The valuation suggests muted expectations for near-term earnings recovery despite sector tailwinds.
Korian’s scale and geographic diversification provide structural advantages in Europe’s elderly care market. However, the outlook remains cautious due to high leverage and operational margin pressures. Success hinges on improving cost efficiency, navigating labor shortages, and monetizing its integrated care model while managing debt obligations.
Company filings, market data
show cash flow forecast
| Fiscal year | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |